Weight loss could mean portfolio gains

An expert discusses ways to invest in a new drug before a key panel review.

By Wall Street Media on MSN Money Jun 28, 2010 1:17PM

Written by Douglas Estadt

 

Adam Warner, our go-to options guy and the author of "Options Volatility Trading" and dailyoptionsreport.com, joins us to discuss alternative ways to invest in VVUS (VVUS) prior to the July 15 panel review date of the company's new weight-loss drug.  The stock is currently in the $10 range for common shares, and it stands to rise substantially if the panel review is positive.

 

  • A bullish approach—buying  calls on the 10s and selling 15s, could triple your money if the panel’s review is positive
  • A bearish approach—buying a put spread (buy 10s, sell 5s)
  • Options expire July 16th, just one day after the panel review
  • FDA’s decision on the new weight-loss drug will be made on October 23 and will depend heavily on the conclusions of the panel review
  • VVUS has another drug following the weight-loss drug that should be more easily approved by the FDA and favorable for VVUS common shares
To hear more on ways to invest in VVUS, view the video below

Visit Wall Street Media. We feature exclusive insights from the world's leading transparent investors.
0Comments

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

124
124 rated 1
282
282 rated 2
455
455 rated 3
624
624 rated 4
642
642 rated 5
665
665 rated 6
610
610 rated 7
460
460 rated 8
287
287 rated 9
167
167 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
KOGKODIAK OIL & GAS Corp10
TWXTIME WARNER Inc10
BBBYBED BATH & BEYOND INC10
FOXATWENTY-FIRST CENTURY FOX Inc CLASS A10
COPCONOCOPHILLIPS9
More

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.